Inhibition of liver fibrosis by solubilized coenzyme Q10: Role of Nrf2 activation in inhibiting transforming growth factor-beta1 expression.

[1]  M. Beal,et al.  Mitochondrial Approaches for Neuroprotection , 2008, Annals of the New York Academy of Sciences.

[2]  C. Frampton,et al.  Coenzyme Q10: an independent predictor of mortality in chronic heart failure. , 2008, Journal of the American College of Cardiology.

[3]  M. R. Kim,et al.  Increased expression of Nrf2/ARE-dependent anti-oxidant proteins in tamoxifen-resistant breast cancer cells. , 2008, Free radical biology & medicine.

[4]  S. Friedman.  Hepatic stellate cells: protean, multifunctional, and enigmatic cells of the liver. , 2008, Physiological reviews.

[5]  S. Reddy,et al.  Genetic dissection of the Nrf2-dependent redox signaling-regulated transcriptional programs of cell proliferation and cytoprotection. , 2007, Physiological genomics.

[6]  K. Kang,et al.  Induction of Glutathione Transferase in Insulin-Like Growth Factor Type I Receptor-Overexpressed Hepatoma Cells , 2007, Molecular Pharmacology.

[7]  R. S. Sohal,et al.  Coenzyme Q, oxidative stress and aging. , 2007, Mitochondrion.

[8]  U. Singh,et al.  Coenzyme Q10 supplementation and heart failure. , 2007, Nutrition reviews.

[9]  P. Govitrapong,et al.  Coenzyme Q10 provides neuroprotection in iron-induced apoptosis in dopaminergic neurons , 2007, Journal of Molecular Neuroscience.

[10]  Yuba Raj Pokharel,et al.  Potent protective effect of isoimperatorin against aflatoxin B1-inducible cytotoxicity in H4IIE cells: bifunctional effects on glutathione S-transferase and CYP1A. , 2006, Carcinogenesis.

[11]  K. Kang,et al.  Antioxidative effects of quercetin-glycosides isolated from the flower buds of Tussilago farfara L. , 2006, Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association.

[12]  M. Sikorska,et al.  Water-soluble formulation of Coenzyme Q10 inhibits Bax-induced destabilization of mitochondria in mammalian cells , 2006, Apoptosis.

[13]  S. Dooley,et al.  N-Acetyl-L-Cysteine abrogates fibrogenic properties of fibroblasts isolated from Dupuytren's disease by blunting TGF-β signalling , 2006, Journal of cellular and molecular medicine.

[14]  G. Giannelli,et al.  Laminin-5 with transforming growth factor-beta1 induces epithelial to mesenchymal transition in hepatocellular carcinoma. , 2005, Gastroenterology.

[15]  Shelly C. Lu,et al.  Nrf1 and Nrf2 Regulate Rat Glutamate-Cysteine Ligase Catalytic Subunit Transcription Indirectly via NF-κB and AP-1 , 2005, Molecular and Cellular Biology.

[16]  Y. Surh,et al.  Resveratrol upregulates heme oxygenase-1 expression via activation of NF-E2-related factor 2 in PC12 cells. , 2005, Biochemical and biophysical research communications.

[17]  S. Morini,et al.  Alpha-SMA expression in hepatic stellate cells and quantitative analysis of hepatic fibrosis in cirrhosis and in recurrent chronic hepatitis after liver transplantation. , 2005, Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver.

[18]  C. Arteaga,et al.  Smad3-ATF3 signaling mediates TGF-beta suppression of genes encoding Phase II detoxifying proteins. , 2005, Free radical biology & medicine.

[19]  S McCarthy,et al.  Paraquat induces oxidative stress and neuronal cell death; neuroprotection by water-soluble Coenzyme Q10. , 2004, Toxicology and applied pharmacology.

[20]  P. Forsmark-Andrée,et al.  Ubiquinol: an endogenous antioxidant in aerobic organisms , 2004, The clinical investigator.

[21]  Jawed Alam,et al.  Curcumin activates the haem oxygenase-1 gene via regulation of Nrf2 and the antioxidant-responsive element. , 2003, The Biochemical journal.

[22]  K. Kang,et al.  Essential role of phosphatidylinositol 3-kinase-dependent CCAAT/enhancer binding protein beta activation in the induction of glutathione S-transferase by oltipraz. , 2003, Journal of the National Cancer Institute.

[23]  Keon Wook Kang,et al.  Oltipraz regenerates cirrhotic liver through CCAAT/enhancer binding protein‐mediated stellate cell inactivation , 2002 .

[24]  D. Playford,et al.  Coenzyme Q10 improves blood pressure and glycaemic control: a controlled trial in subjects with type 2 diabetes , 2002, European Journal of Clinical Nutrition.

[25]  B. Sarter.  Coenzyme Q10 and cardiovascular disease: a review. , 2002, The Journal of cardiovascular nursing.

[26]  Judy W. M. Cheng,et al.  Use of alternative pharmacotherapy in management of cardiovascular diseases. , 2002, The American journal of managed care.

[27]  K. Kang,et al.  Inhibition of dimethylnitrosamine-induced liver fibrosis by [5-(2-pyrazinyl)-4-methyl-1,2-dithiol-3-thione] (oltipraz) in rats: suppression of transforming growth factor-beta1 and tumor necrosis factor-alpha expression. , 2002, Chemico-biological interactions.

[28]  F. L. Crane,et al.  Biochemical Functions of Coenzyme Q10 , 2001, Journal of the American College of Nutrition.

[29]  M. Caruso,et al.  Increased oxidative stress in dimethylnitrosamine-induced liver fibrosis in the rat: Effect of N-acetylcysteine and interferon-α , 2001 .

[30]  D. Schuppan,et al.  TGFβ1 in liver fibrosis: time to change paradigms? , 2001 .

[31]  K. Kang,et al.  Activation of phosphatidylinositol 3-kinase and Akt by tert-butylhydroquinone is responsible for antioxidant response element-mediated rGSTA2 induction in H4IIE cells. , 2001, Molecular pharmacology.

[32]  C. Wolf,et al.  The Cap'n'Collar basic leucine zipper transcription factor Nrf2 (NF-E2 p45-related factor 2) controls both constitutive and inducible expression of intestinal detoxification and glutathione biosynthetic enzymes. , 2001, Cancer research.

[33]  M. Nishikawa,et al.  Effect of Treatment with 3-Hydroxy-3-methylglutaryl Coenzyme A Reductase Inhibitors on Serum Coenzyme Q10 in Diabetic Patients , 1999, Arzneimittelforschung.

[34]  A. Ooshima,et al.  Blockade of type beta transforming growth factor signaling prevents liver fibrosis and dysfunction in the rat. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[35]  J. Wondergem,et al.  Detection and quantitative measurement of transforming growth factor-beta1 (TGF-beta1) gene expression using a semi-nested competitive PCR assay. , 1999, Cytokine.

[36]  Y. Kaneda,et al.  Hepatocyte growth factor gene therapy of liver cirrhosis in rats , 1999, Nature Medicine.

[37]  V. Carloni,et al.  Signal transduction in hepatic stellate cells. , 2008, Liver.

[38]  S. Friedman,et al.  Transcriptional Activation of Transforming Growth Factor β1 and Its Receptors by the Kruppel-like Factor Zf9/Core Promoter-binding Protein and Sp1 , 1998, The Journal of Biological Chemistry.

[39]  Y. Toyoki,et al.  Semiquantitative evaluation of hepatic fibrosis by measuring tissue hydroxyproline. , 1998, Hepato-gastroenterology.

[40]  S. Seki,et al.  Effect of antioxidants, resveratrol, quercetin, and N‐acetylcysteine, on the functions of cultured rat hepatic stellate cells and kupffer cells , 1998, Hepatology.

[41]  J. Panés,et al.  Effects of silymarin in alcoholic patients with cirrhosis of the liver: results of a controlled, double-blind, randomized and multicenter trial. , 1998, Journal of hepatology.

[42]  R. Hammer,et al.  Hepatic fibrosis, glomerulosclerosis, and a lipodystrophy-like syndrome in PEPCK-TGF-beta1 transgenic mice. , 1997, The Journal of clinical investigation.

[43]  C. Dubois,et al.  Transforming Growth Factor- β1 Is a Potent Inhibitor of Glutathione Synthesis in the Lung Epithelial Cell Line A549: Transcriptional Effect on the GSH Rate-limiting Enzyme γ -Glutamylcysteine Synthetase , 1997 .

[44]  Y. Kuboki,et al.  Measurement of histidinohydroxylysinonorleucine and hydroxyproline in skin collagen by reversed-phase high-performance liquid chromatography after 9-fluorenylmethyl chloroformate labeling. , 1997, Analytical biochemistry.

[45]  Gressner Am.  Transdifferentiation of hepatic stellate cells (Ito cells) to myofibroblasts: a key event in hepatic fibrogenesis. , 1996 .

[46]  J. George,et al.  Molecular characteristics of dimethylnitrosamine induced fibrotic liver collagen. , 1996, Biochimica et biophysica acta.

[47]  A. Gressner.  Transdifferentiation of hepatic stellate cells (Ito cells) to myofibroblasts: a key event in hepatic fibrogenesis. , 1996, Kidney international. Supplement.

[48]  K. Matsumoto,et al.  Hepatocyte growth factor suppresses the onset of liver cirrhosis and abrogates lethal hepatic dysfunction in rats. , 1995, Journal of biochemistry.

[49]  G. Kajiyama,et al.  Acetaminophen-induced hepatic injury in mice: the role of lipid peroxidation and effects of pretreatment with coenzyme Q10 and alpha-tocopherol. , 1995, Free radical biology & medicine.

[50]  Y. Matsuzawa,et al.  Suppression of antioxidative enzyme expression by transforming growth factor-beta 1 in rat hepatocytes. , 1994, The Journal of biological chemistry.

[51]  S. Friedman.  The Cellular Basis of Hepatic Fibrosis -- Mechanisms and Treatment Strategies , 1993 .

[52]  B. Fanburg,et al.  Reduction of glutathione is associated with growth restriction and enlargement of bovine pulmonary artery endothelial cells produced by transforming growth factor-beta 1. , 1992, American journal of respiratory cell and molecular biology.

[53]  H. Tsukamoto,et al.  Experimental Models of Hepatic Fibrosis: A Review , 1990, Seminars in liver disease.

[54]  K. Folkers,et al.  Coenzyme Q10: clinical benefits with biochemical correlates suggesting a scientific breakthrough in the management of chronic heart failure. , 1990, International journal of tissue reactions.

[55]  M. Sporn,et al.  Characterization of the promoter region of the human transforming growth factor-beta 1 gene. , 1989, The Journal of biological chemistry.

[56]  K. Dohi,et al.  The role of lipid peroxidation in endotoxin-induced hepatic damage and the protective effect of antioxidants. , 1987, Surgery.

[57]  M. Cocchi,et al.  Coenzyme Q10 levels in rat heart of different age. , 1980, Biochemistry and experimental biology.